Spacelabs Capno Module
by Spacelabs Healthcare (Washington), Inc
Spacelabs Capno Module (92517) is a patient monitoring system module (FDA Class II; FDA product code CCK, Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase) made by Spacelabs Healthcare (Washington), Inc, cleared under FDA 510(k) K130112 on 21 Mar 2013 and listed in FDA GUDID since 19 Sep 2016 (UDI-DI 10841522113093), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10841522113093 | Date19 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK130112 | Date21 Mar 2013 | StatusActive |
Official records
- AccessGUDID record 10841522113093
- FDA 510(k) database K130112
From the FDA record
- Device description
- CAPNO MODULE,92517
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K130112 decided 21 Mar 2013 Active
- FDA GUDID UDI-DI 10841522113093 listed 19 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K130112
- Listed FDA GUDID 10841522113093
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Spacelabs
- Generic name
- Patient monitoring system module, carbon dioxide
- Model / Ref / Catalog
- Capno Module, 92517
- Primary DI / UDI-DI
- 10841522113093
- 510(k) Number
- FDA product code
- CCK
- GMDN term
- Patient monitoring system module, carbon dioxide
- Device class
- Class II
- Regulation number
- 868.1400
- GUDID distribution status
- In Commercial Distribution
Other devices from Spacelabs Healthcare (Washington), Inc
See all devices from Spacelabs Healthcare (Washington), Inc →